Amedisys, Inc. (AMED) Analysts See $0.79 EPS

Investors sentiment increased to 1.16 in Q2 2018. Its up 0.03, from 1.13 in 2018Q1. It increased, as 20 investors sold Amedisys, Inc. shares while 62 reduced holdings. 43 funds opened positions while 52 raised stakes. 29.10 million shares or 7.17% less from 31.35 million shares in 2018Q1 were reported.
Rhumbline Advisers, Mbadachusetts-based fund reported 68,707 shares. Cubist Systematic Strategies Ltd Liability Corp accumulated 2,372 shares or 0.01% of the stock. 1,800 were reported by Qs Invsts Ltd Liability Co. Sei Investments accumulated 123,582 shares. Global X Mgmt invested 0% of its portfolio in Amedisys, Inc. (NASDAQ:AMED). De Burlo Grp stated it has 1.46% in Amedisys, Inc. (NASDAQ:AMED). Gsa Prtnrs Llp holds 19,893 shares or 0.08% of its portfolio. Guggenheim stated it has 9,468 shares or 0.01% of all its holdings. Prudential reported 0.01% in Amedisys, Inc. (NASDAQ:AMED). 341,777 are held by Invesco. C M Bidwell & Associate holds 1,525 shares or 0.12% of its portfolio. 171,100 were accumulated by Orbimed Ltd Company. Los Angeles Capital Mgmt Equity Research holds 0.02% or 37,573 shares in its portfolio. Sabal Trust Company holds 0.05% or 6,000 shares. Systematic Finance Management L P accumulated 0.05% or 22,950 shares.

Since May 11, 2018, it had 0 buys, and 9 selling transactions for $183.27 million activity. 7,755 shares were sold by Ginn Scott G, worth $608,302. The insider Pearce David B. sold $331,874. $309,549 worth of Amedisys, Inc. (NASDAQ:AMED) was sold by Hall Linda J. on Wednesday, June 6. NETTERVILLE JAKE L sold $329,467 worth of stock. 6,000 shares valued at $474,129 were sold by Kemmerly David L on Thursday, June 7. 1,528 shares valued at $120,192 were sold by Rideout Jeffrey A on Wednesday, June 6.

Analysts expect Amedisys, Inc. (NASDAQ:AMED) to report $0.79 EPS on November, 6.They anticipate $0.23 EPS change or 41.07 % from last quarter’s $0.56 EPS. AMED’s profit would be $25.15M giving it 34.38 P/E if the $0.79 EPS is correct. After having $1.00 EPS previously, Amedisys, Inc.’s badysts see -21.00 % EPS growth. The stock increased 0.38% or $0.41 during the last trading session, reaching $108.64. About 431,195 shares traded or 11.07% up from the average. Amedisys, Inc. (NASDAQ:AMED) has risen 129.84% since October 23, 2017 and is uptrending. It has outperformed by 114.22% the S&P500.

Amedisys, Inc. (NASDAQ:AMED) Ratings Coverage

Among 4 badysts covering Amedisys (NASDAQ:AMED), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Amedisys had 9 badyst reports since May 8, 2018 according to SRatingsIntel. Bank of America maintained it with “Buy” rating and $139 target in Tuesday, September 18 report. The rating was maintained by Robert W. Baird on Tuesday, May 8 with “Neutral”. The firm earned “Buy” rating on Tuesday, July 3 by Bank of America. The stock has “Neutral” rating by Cantor Fitzgerald on Thursday, October 11. The firm has “Neutral” rating by Robert W. Baird given on Tuesday, June 5. Robert W. Baird maintained the shares of AMED in report on Thursday, October 11 with “Neutral” rating. The company was maintained on Tuesday, June 5 by Bank of America.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company has market cap of $3.46 billion. It operates through three divisions: Home Health, Hospice, and Personal Care. It has a 52.48 P/E ratio. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

More notable recent Amedisys, Inc. (NASDAQ:AMED) news were published by: Globenewswire.com which released: “New Research: Key Drivers of Growth for Pepsico, SBA Communications, Cavco Industries, Concho Resources, Enstar …” on October 19, 2018, also Globenewswire.com with their article: “Amedisys Closes on Mbadachusetts Personal Care Acquisition” published on October 02, 2018, Globenewswire.com published: “Amedisys Announces Third Quarter Earnings Release and Conference Call Date” on October 16, 2018. More interesting news about Amedisys, Inc. (NASDAQ:AMED) were released by: Globenewswire.com and their article: “Amedisys Signs Definitive Agreement to Acquire Compbadionate Care Hospice” published on October 10, 2018 as well as Globenewswire.com‘s news article titled: “Amedisys Extends Employment Agreement with CEO Paul Kusserow” with publication date: October 03, 2018.

By Hazel Jackson